Botanical Nomenclature for Herbal Medicines and Natural Products: Its Significance for Pharmacovigilance

Allkin, Bob; Patmore, Kristina

doi:10.1007/978-3-031-07275-8_8

Cited by 5 publications

(4 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Despite the use of Latinized names in botanical nomenclature, it does not inherently guarantee legitimacy or scientific precision. It was found that the pharmaceutical name “Cimicifugae rhizome” was employed by different pharmacopoeias to refer to substances derived from five different plant species, which have differing chemistries and uses [ 40 ]. Rigorous quality control, including information on the identity of the plant species used, is of utmost importance to guarantee products that are safe to use by the consumer.…”

Section: Discussionmentioning

confidence: 99%

Analysis of Safety Concerns on Herbal Products with Assumed Phytoestrogenic Activity

et al. 2023

View full text Add to dashboard Cite

Phytoestrogens (PEs) are plant-based compounds that can interact with estrogen receptors and are mainly used to treat menopausal complaints. However, the safety of products with assumed phytoestrogenic activity is not fully understood. This study aimed to identify plant species with assumed phytoestrogenic activity, review existing literature on their use and safety, and critically evaluate adverse reaction (AR) reports of single-herb, multi-herb, and mixed-multiple products, as submitted to the Netherlands Pharmacovigilance Centre Lareb and to VigiBase of the World Health Organization (WHO). In the Lareb database, the most commonly reported plant species to cause ARs (total of 67 reports) were Actaea racemosa L. (black cohosh) (47.8%), Humulus lupulus L. (hops) (32.8%), and Glycine max (L.) Merr. (soybean) (22.4%). In the VigiBase database (total of 21,944 reports), the top three consisted of Glycine max (L.) Merr. (71.4%), Actaea racemosa L. (11.6%), and Vitex agnus-castus L. (chaste tree) (6.4%). In the scoping review (total of 73 articles), Actaea racemosa L. (30.1%), Glycine max (L.) Merr. (28.8%), and Trifolium pratense L. (13.7%) were the most frequently mentioned plant species. ARs were most frequently reported in the system organ classes “gastrointestinal disorders”, “skin and subcutaneous tissue disorders”, “reproductive system and breast disorders”, and “general disorders and administration site conditions”. Furthermore, from the scoping review, it appeared that the use of products with assumed phytoestrogenic activity was associated with postmenopausal bleeding. It was concluded that, while the potential benefits of products with assumed phytoestrogenic activity have been extensively pursued, the potential occurrence of ARs after using these products is less well understood. This study highlights the need for further investigation and careful monitoring of these products to better understand their effects and ensure the safety and well-being of individuals using them.

show abstract

Section: Discussionmentioning

confidence: 99%

Analysis of Safety Concerns on Herbal Products with Assumed Phytoestrogenic Activity

et al. 2023

View full text Add to dashboard Cite

show abstract

“…Validation via MPNS served to resolve spelling mistakes or inconsistencies in the names as published in the literature and ensured scientific integrity. This avoided a single plant being listed multiple times under alternative synonyms ( Allkin and Patmore, 2022 ).…”

Section: Methodsmentioning

confidence: 99%

“…Some of the suggested identities are questionable and potentially erroneous, as pointed out by Riddle (1996) or Raven et al (2000) and as illustrated in detail by Evergetis and Haroutounian (2015) ; ii) botanical names provided in those references are themselves often ambiguous or imprecise due to the use of synonyms, illegitimate or invalid names, and through lacking complete author citations. The use of inappropriate or erroneous scientific nomenclature may compromise the reliability or value of the published work ( Rivera et al, 2014 ) and prevent comprehensive access to relevant past research ( Allkin and Patmore, 2022 ); iii) uncritical adoption of previously suggested identities can be misleading. Various studies indicate that consideration of the specific phytogeographical, cultural-historical and philological aspects of a given text is indispensable for drawing reliable conclusions (see e.g.…”

Section: Introductionmentioning

confidence: 99%

A systematic methodology to assess the identity of plants in historical texts: A case study based on the Byzantine pharmacy text John the Physician's Therapeutics

Lardos,

Patmore,

Allkin

et al. 2024

Journal of Ethnopharmacology

View full text Add to dashboard Cite

“…По данным Allkin и Patmore [17], ежегодно публикуется около 10 000 статей, содержащих изменения научных названий высших растений, из которых не менее 1500 изменений относятся к лекарственным растениям.…”

Section: заключениеunclassified

Outdated latin names of medicinal plants in the monographs of the State Pharmacopoeia of the Russian Federation, XIV edition (review)

Povydysh,

Goncharov

2024

Razrabotka i registraciâ lekarstvennyh sredstv

View full text Add to dashboard Cite

Introduction. The State Pharmacopoeia of the Russian Federation, XIV-th edition (SP XIV), includes 107 monographs devoted to medicinal plant materials. The purpose of the study was to identify incorrect Latin names of medicinal plants in the monographs of the XIV edition, study the officially accepted Latin names and taxonomic position of medicinal plants in accordance with the contemporary system of flowering plants, and justify the need to make changes in subsequent editions of the pharmacopoeia.Text. 44 cases of incorrect Latin names were found. This is explained by the fact that when developing new pharmacopoeia monographs, either Latin names historically established in Russian pharmacognosy were used, or names that were legal at the time of the last edition of the Pharmacopoeia. The bulk of nomenclatural changes are associated with the adoption of the new APG system of flowering plants, based on molecular genetic data. The paper contains lists of plants for which the State Pharmacopoeia XIV contains an incorrect name of the genus, species, family or author, indicating the correct name, as well as comments on the rules of modern botanical nomenclature.Conclusion. In connection with the prospects for processing monographs on medicinal plant raw materials for the State Pharmacopoeia XV-th edition, as well as the EAEU Pharmacopoeia, the harmonization of the nomenclature of pharmacopoeial plants with modern international requirements becomes especially relevant.

show abstract

Botanical Nomenclature for Herbal Medicines and Natural Products: Its Significance for Pharmacovigilance

Cited by 5 publications

References 23 publications

Analysis of Safety Concerns on Herbal Products with Assumed Phytoestrogenic Activity

Analysis of Safety Concerns on Herbal Products with Assumed Phytoestrogenic Activity

A systematic methodology to assess the identity of plants in historical texts: A case study based on the Byzantine pharmacy text John the Physician's Therapeutics

Outdated latin names of medicinal plants in the monographs of the State Pharmacopoeia of the Russian Federation, XIV edition (review)

Contact Info

Product

Resources

About